30.06.2013 Views

Sick and Tired: Understanding and Managing Sleep Difficulties in ...

Sick and Tired: Understanding and Managing Sleep Difficulties in ...

Sick and Tired: Understanding and Managing Sleep Difficulties in ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Outcome Measures:<br />

Participants were engaged <strong>in</strong> the study for a three week period. In week one (the<br />

basel<strong>in</strong>e week) participants were asked to complete st<strong>and</strong>ardised questionnaires <strong>and</strong><br />

questions regard<strong>in</strong>g their age, gender, symptom duration, co-morbid conditions,<br />

employment status, hours of paid work, <strong>and</strong> if they were required to undertake any shift<br />

work.<br />

Mood was assessed us<strong>in</strong>g the Hospital Anxiety <strong>and</strong> Depression Scale (HADS)<br />

(Zigmond & Snaith, 1983). This scale has been widely used for assess<strong>in</strong>g levels of<br />

anxiety <strong>and</strong> depression <strong>in</strong> patients with medical problems (Herrmann, 1997). The scale<br />

consists of 14 questions that ask participants how they have been feel<strong>in</strong>g over the past<br />

week. There are two subscales (anxiety <strong>and</strong> depression) <strong>and</strong> subscale scores range<br />

between 0-21 (0-7 normal, 8-10 mild, 11-14 moderate <strong>and</strong> 15-21 represent<strong>in</strong>g a severe<br />

level of anxiety/depression). The HADS has been found to have high reasonable<br />

<strong>in</strong>ternal consistency of between 0.68 to.093 (mean.83) for the anxiety subscale <strong>and</strong><br />

between 0.67 to 0.90 (mean 0.82) for the depression subscales (Bjell<strong>and</strong>, Dahl, Haug, &<br />

Neckelmann, 2002); <strong>and</strong> is sensitive to treatment related change with test retest<br />

correlations at six weeks of 0.70 (Herrmann, 1997). As high levels of depression <strong>and</strong><br />

anxiety have been found <strong>in</strong> people with FMS (Epste<strong>in</strong> et al., 1999) this measure was<br />

utilised to assess levels of anxiety or depression between the two groups, <strong>and</strong> to reveal<br />

if there if there were any differences that would need to be accounted for <strong>in</strong> the analysis.<br />

Primary outcome measures<br />

Actigraphy<br />

As highlighted <strong>in</strong> Chapter Two, actigraphy can be used as an objective measure of<br />

movement (where periods of <strong>in</strong>activity are <strong>in</strong>dicative of sleep or rest) <strong>and</strong> can also<br />

provid<strong>in</strong>g a measure of activity levels dur<strong>in</strong>g the day <strong>and</strong> over night <strong>in</strong> a naturalistic<br />

sett<strong>in</strong>g (Smith & Haythornthwaite, 2004). This study utilised actigraphs developed by<br />

Cambridge Neurotechnology Ltd., which measured changes <strong>in</strong> acceleration created by<br />

movement of the arm <strong>and</strong> summed over one m<strong>in</strong>ute epoch <strong>in</strong>tervals. In order to account<br />

for the variability <strong>in</strong> sleep quality over time, participants were asked to wear the<br />

actigraph throughout the day <strong>and</strong> night for the three week duration of the study.<br />

135

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!